Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has actually obtained a considerable inc...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing already scooped up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscle d...

FDA fragments adcomm for Applied's rare illness medication

.After dismissing the decision meeting for Applied Therapeutics' metabolic disorder medicine govores...

Novo inks $600M NanoVation bargain to analyze genetic drugs ex-liver

.Novo Nordisk is actually continuing its press into genetic medicines, agreeing to pay NanoVation Re...

Innovent web links cytokine to colorectal cancer feedbacks

.Innovent Biologics has actually made the case that its gate inhibitor-cytokine blend healthy protei...

Merck, Daiichi ADC attacks objective in period 3 bronchi cancer study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens AI focus along with collab to choose cancer targets

.Five months after Rakovina Therapies turned towards artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism drug favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has actually become a potential hazard to BioMarin's Voxzogo, reporting period 3 gr...

Despite ph. 3 miss out on, Alkeus finds course ahead of time for eye illness possession

.Though Alkeus Pharmaceuticals' dental eye ailment possession fell short to significantly minimize g...

Kairos goes social with $6M IPO to finance trials of cancer medicine

.Along with a trio of biotechs striking the Nasdaq on Friday, it was simple to miss a smaller-scale ...